Canada - English - Health Canada

teva canada limited - ipratropium bromide; salbutamol (salbutamol sulfate) - solution - 0.5mg; 2.5mg - ipratropium bromide 0.5mg; salbutamol (salbutamol sulfate) 2.5mg - antimuscarinics antispasmodics

Canada - English - Health Canada

pharmascience inc - ipratropium bromide - solution - 125mcg - ipratropium bromide 125mcg - antimuscarinics antispasmodics

Canada - English - Health Canada

pharmascience inc - ipratropium bromide - solution - 250mcg - ipratropium bromide 250mcg - antimuscarinics antispasmodics

Canada - English - Health Canada

pharmascience inc - ipratropium bromide - solution - 250mcg - ipratropium bromide 250mcg - antimuscarinics antispasmodics

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - ipratropium bromide monohydrate, quantity: 522 microgram (equivalent: ipratropium bromide, qty 500 microgram) - inhalation, conventional - excipient ingredients: sodium chloride; water for injections; hydrochloric acid - for moderate asthma attacks; chronic forms of asthma; asthma in patients with diminished cardiac reserve; chronic obstructive bronchitis with bronchospasm; bronchospasm during or after surgery; use during assisted ventilation with a respirator.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - ipratropium bromide monohydrate, quantity: 261 microgram (equivalent: ipratropium bromide, qty 250 microgram) - inhalation, conventional - excipient ingredients: water for injections; hydrochloric acid; sodium chloride - for moderate asthma attacks; chronic forms of asthma; asthma in patients with diminished cardiac reserve; chronic obstructive bronchitis with bronchospasm; bronchospasm during or after surgery; use during assisted ventilation with a respirator.

Australia - English - Department of Health (Therapeutic Goods Administration)

boehringer ingelheim pty ltd - ipratropium bromide monohydrate, quantity: 21 microgram/actuation - inhalation, pressurised - excipient ingredients: ethanol absolute; citric acid; purified water; norflurane - atrovent metered aerosol is indicated as a bronchodilator for maintenance treatment of bronchospasm associated with asthma and chronic obstructive pulmonary disease (copd).

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - ipratropium bromide monohydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

boehringer ingelheim pty ltd - ipratropium bromide monohydrate, quantity: 522 microgram/ml (equivalent: ipratropium bromide, qty 500 microgram/ml) - inhalation, conventional - excipient ingredients: sodium chloride; hydrochloric acid; purified water - moderate asthmatic attacks; chronic forms of asthma; asthma in patients with diminished cardiac reserve; chronic obstructive bronchitis with bronchospasm; bronchospasm during or after surgery, use during assisted ventilation with a respirator. administration of atrovent via a nebuliser is intended for those patients who cannot use a metered dose aerosol.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - ipratropium bromide monohydrate -